Search:

< Go Back

Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo
Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Denmark For The Treatment Of Chronic Diabetic Macular Edema
Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs
SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research
First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development
Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders
Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Sclerosis to be Presented at 2014 Joint ACTRIMS-ECTRIMS Meeting
Synageva BioPharma™ Reports Second Quarter 2014 Financial Results
The 29th Annual Great Sports Legends Dinner To Honor Hakeem Olajuwon, Warren Sapp, Pedro Martinez, Mary Lou Retton, Bill Cowher And More English
Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant
Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
New Vitamin D Research: Supplementation Is Best Way To Improve Vitamin D Levels
Entinostat Improves Treatment Outcomes When Combined with Immune Checkpoint Blockade in Preclinical Tumor Models
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Orexigen Receives CHMP Day 180 List of Outstanding Issues English
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion™ in the new facility.
GenSpera Announces US Patent for Methods and Compositions for the Detection, Imaging and Treatment of Cancer
Study Shows that RapidArc® Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife® in the Treatment of Multiple Brain Metastases
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars
AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001
Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit
PCORI Board Approves $54.8 Million in Funding for Patient-Centered Comparative Effectiveness Research Projects
New Technology May Improve Visualization Of The Brain During Stroke Treatment English
Factors Causing Multiple Disabilities Among Children-The Pharma-Media Alliance Never Wants The Public To Know-: Unveils Qadhi A.Z. Al-Hafi
Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo
Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine
Cognitive-Enhancing Citicoline Found to Improve Motor Speed and Attention in Adolescents
Neurotrope Initiates Phase 2a Study of Bryostatin for the Treatment of Alzheimer's Disease - Doses First Patients
Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000
Bioniche Announces Submission of Orphan Drug Designation Application for MCNA in the United States English English
ATL1103 Acromegaly Phase II Trial Dosing Completed
Kurbo Health Launches First Proven Program to Combat Childhood Obesity Using Mobile Tools
Phosphagenics Provides Update on Opioid Patch Program
EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
KaloBios Provides Update on KB001-A Partnership and Clinical Status
IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
OHSU Knight Cancer Challenge attracts $100 million gift
BiologicTx® Announces Discovery 2 Life™ Platform (D2L™) and Three-Year Transplant Clinical Outcomes at The World Transplant Congress
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427
Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
"Graying" Population of Infertility Patients Brings New Challenges to Medical Practice and Society, Study at Center for Human Reproduction Finds
Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients
QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™

< Prev Next >
PR Newswire - United Business Media